维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Kamstrup PR"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Penetrance of NOD2/CARD15 genetic variants in the general population显示文摘	Yazdanyar S Kamstrup PR Tybjaerg-Hansen A	2010	CMAJ2010，182，7：	1
2	GeneticaUy elevated lipoprotein(a) and increased risk of myocardial infarction 显示文摘	Kamstrup PR Tybjaerg-Hansen A Steffensen R	2009	JAMA2009，301，22：	1
3	Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study 显示文摘	Kamstrup PR Benn M Tybaerg-Hansen A	2008	Circulation2008，117，2：	1
4	Lipoprotein ( a ) and risk of type 2 diabetes显示文摘	Mora S Kamstrup PR Rifai N	2010	Clin Chem2010，56，8：	1
5	Genetically elevated lipoprotein(a) and increased risk of myocardial infarction 显示文摘	Kamstrup PR Tybjaerg-Hansen A Steffensen R	2009	JAMA2009，301，22：	1
6	脂蛋白机采对脂蛋白a相关心血管病的影响:前瞻性5年随访研究显示文摘自2008年,进展性高脂蛋白a血症合并心血管病(lipoprotein a-hyperlipoproteinemia,Lp(a)-HLP)已是德国常规机采脂蛋白(lipoprotein apheresis,LA)的适应证。该研究旨在评估LA的长期预防效果,并分析载脂蛋白a基因型和表型的临床相关性。方法:该前瞻性多中心临床研究纳入170例Lp(a)-HLP合并进展性心血管病的患者(平均基线低密度脂蛋白胆固醇2.56、治疗后1.72mmol/L),确诊时年龄中位数为48.9岁。	刘莉叶鹏 Roeseler E Julius U Heigl F Spitthoever R Heutling D Breitenberger P Leebmann J Lehmacher W Kamstrup PR Nordestgaard BG Maerz W Noureen A Schmidt K Kronenberg F Heibges A Klingel R Pro(a)LiFe-Study Group	2016	中华高血压杂志2016，24，8：	1
7	Elevated lipoprotein (a) and risk of aortic valve stenosis in the general population显示文摘	Kamstrup PR Tybjaerg-Hansen A Nordestgaard BG	2014	J Am Coll Cardiol2014，63，：	1
8	Extreme lipoprotein (a) levels and improved cardiovascular risk prediction 显示文摘	Kamstrup PR Tybjzerg-Hansen A Nordestgaard BG	2013	J Am Coil Cardiol2013，61，11：	1
9	Extreme lipopmtein (a) lev- els and risks of myocardial infarction in the general population; the Copenhagen City Heart Study 显示文摘	Kamstrup PR Benn M Tybjaerg A er al	2008	Circulation2008，117，2：	1
10	Genetic evidence that lipoprotein (a) associates with atherosclerotic stenosis rather than venous thrombosis 显示文摘	Kamstrup PR Tybjaerg-Hansen A Nordestgaard BG	2012	Arterioscler Thr- omb Vasc Biol2012，32，7：	1
11	Lipo- protein (a) and risk of myocardial infarction-genetic epide- miologic evidence of causality 显示文摘	Kamstrup PR Tybjzerg-Hansen A Nordestgaard BG	2011	Scand J Clin Lab Invest2011，71，2：	1
12	Pentanucleotide repeat polymorphism, lipoprotein ( a ) levels, and risk of ischemic heart disease 显示文摘	Kamstrup PR Tybjaerg-Hansen A Steffensen R	2008	J Clin Endocrinol Metab2008，93，10：	1
13	Genetic evi- dence that lipoprotein (a) associates with atherosclerotie stenosis rather than venous thrombosis 显示文摘	Kamstrup PR Tybj~erg-Hansen A Nordestgaard BG	2012	Arterioscler Thromb Vasc Biol2012，32，7：	1
14	Ex tremelipoprotein(a) leveIs and risks of myocardial infarction in th general population: the copenhagen city Heart study 显示文摘	Kamstrup PR Benn M Tybjaerg-Hansen A	2008	Circulation2008，117，2：	1
15	Genetically elevated lipoprotein(a) and increased risk of myocardial infarction 显示文摘	Kamstrup PR Tybjaerg-Hansen A Steffensen R	2009	JAMA2009，301，22：	1
16	Hepatic lipase,genetically elevated high-density lipoprotein,and risk of ischemic cardiovascular disease显示文摘	Johannsen TH Kamstrup PR Andersen RV	2009	J Clin Endocrinol Metab2009，94，：	1
17	Lipoprotein(a) and risk of type 2 diabetes显示文摘	Mora S Kamstrup PR Rifai N	2010	Clin Chem2010，56，8：	1
18	Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study显示文摘	Kamstrup PR Benn M Tybjaerg-Hansen A	2008	Circulation2008，117，：	1
19	Extremelipoprotein(a)levels and risk of myocardial infarction in the general population:the Copenhagen City Heart Study显示文摘	Kamstrup PR Benn M Tybaerg-Hansen A	2008	Circulation2008，117，2：	1
20	Extreme lipoprotein(a)levels and risk of myocardial infarction in the general population:the Copenhagen city heart study显示文摘	Kamstrup PR Benn M Tybaerg-Hansen A	2008	Circulation2008，117，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示